Corvus Pharmaceuticals, Inc.
Corvus Pharmaceuticals, Inc.（CRVS）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
crvs · 股价预测 · 13 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 13 位华尔街分析师
Buy
13 位分析师
共识
评级分布
12 个月目标价
High
$42.00
Consensus
$33.17
+195.9% upside
Low
$27.00
Median: $31 · Last Close: $11.21
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$33.17
195.9% upside
High Target
$42
274.7%
Low Target
$27
140.9%
Current Price
$11.21
as of today
Based on analyst price targets, the CRVS stock price prediction for the next 12 months ranges from $27 to $42. The consensus CRVS price forecast of $33.17 implies 195.9% upside from the current price of $11.21.
短期股价预测
Bear算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $10.65 | ↓ 5.00% |
1-day model range: $10.53–$10.77. Peak: $10.77 (-5.00%).
长期股价预测
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · CRVS · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-03-13 | Oppenheimer | Maintains | Outperform→Outperform |
| 2026-01-22 | Jefferies | Maintains | Buy→Buy |
| 2026-01-21 | Oppenheimer | Maintains | Outperform→Outperform |
| 2026-01-21 | Barclays | Maintains | Overweight→Overweight |
| 2026-01-20 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-05-20 | Mizuho | Maintains | Outperform→Outperform |
| 2025-05-09 | Oppenheimer | Maintains | Outperform→Outperform |
| 2025-03-26 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-03-26 | Oppenheimer | Maintains | Outperform→Outperform |
| 2025-01-14 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Corvus Pharmaceuticals, Inc. (CRVS) stock. Of the recent 41 rating actions, 1 were upgrades and 2 were downgrades. 13 analysts currently cover CRVS.
分析师推荐趋势
CRVS analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$-0M
↓ 100.6% YoY
Revenue Next Year
$5M
↓ 2372.8% YoY
EPS This Year
$-0.68
EPS Next Year
$-0.85
↑ 25.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast CRVS EPS of $-0.68 for the current fiscal year, based on estimates from 4 analysts. The CRVS revenue forecast is $-0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
CRVS 股价预测由两类独立数据源支撑：来自 13 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。CRVS 的共识目标价为 $33.17（+195.9% 上行空间），分析师共识为 Buy。
CRVS 的短期预测（明日）为 $10.65（-5.00%）。
Corvus Pharmaceuticals, Inc. 在 NASDAQ 上市，代码 CRVS。CRVS 在 2027 年的整体展望偏积极，在覆盖分析师中约 92% 对应 Buy 共识。
常见问题
CRVS 预测 · 8 个问题根据 13 位华尔街分析师，CRVS 的 12 个月平均目标价为 $33.17，最高 $42.00、最低 $27.00。若有图表，中位目标价可在上方查看。相对当前价 $11.21，隐含约 +195.9% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.